The Medical Letter on Drugs and Therapeutics
Drugs for Acne
November 30, 2020 (Issue: 1612)Acne is common among adolescents and young adults, but its prevalence appears to have increased in people of all ages due to prolonged wearing of masks during the COVID-19 pandemic. Guidelines for treatment of acne were last published in 2016.
- S Giacalone et al. Facial dermatoses in the general population due to wearing of personal protective masks during the COVID-19 pandemic: first observations after lockdown. Clin Exp Dermatol 2020 July 13 (epub).
- AL Zaenglein et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74:945.
- Minocycline foam (Amzeeq) for acne. Med Lett Drugs Ther 2020; 62:68.
- Trifarotene (Aklief) – a new topical retinoid for acne. Med Lett Drugs Ther 2019; 61:195.
- A Hebert et al. Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials. JAMA Dermatol 2020; 156:621.
- Sarecycline (Seysara) – another oral tetracycline for acne. Med Lett Drugs Ther 2019; 61:43.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.